AIM ImmunoTech (AIM) Amortizatization of Intangibles (2010 - 2025)
AIM ImmunoTech's (AIM) quarterly Amortizatization of Intangibles came in at $69000.0 in Q3 2025, up 281.58% YoY from $18082.8 in Q3 2024, and down 42.02% on a QoQ basis from $119000.0 in Q2 2025.
AIM ImmunoTech (AIM) Amortizatization of Intangibles (2010 - 2025) Analysis & Trends
AIM ImmunoTech (AIM) has 8 years of Amortizatization of Intangibles data on file, last reported at $69000.0 in Q3 2025.
- Quarterly Amortizatization of Intangibles rose 281.58% year-over-year to $69000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $214000.0 (down 32.92% YoY) and the FY2014 annual result came in at $477000.0, up 143.37% from the prior year.
- Amortizatization of Intangibles slipped to $69000.0 in Q3 2025, from $119000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $197000.0 in Q2 2024 to a low of -$38000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | AIM ImmunoTech | 4.43 Mn | -5.53 Mn | 21,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 69,000.00 |
| Sep 30, 2025 | 69,000.00 |
| Jun 30, 2025 | 119,000.00 |
| Jun 30, 2025 | 119,000.00 |
| Mar 31, 2025 | 64,000.00 |
| Mar 31, 2025 | 64,000.00 |
| Sep 30, 2024 | -38,000.00 |
| Sep 30, 2024 | -38,000.00 |
| Jun 30, 2024 | 197,000.00 |
| Jun 30, 2024 | 197,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Sep 30, 2015 | 87,000.00 |
| Sep 30, 2015 | 87,000.00 |
| Jun 30, 2015 | 8,000.00 |
| Jun 30, 2015 | 8,000.00 |
| Mar 31, 2015 | 71,000.00 |
| Mar 31, 2015 | 71,000.00 |
| Dec 31, 2014 | 63,000.00 |
| Dec 31, 2014 | 63,000.00 |